Mensch, Barbara S.
Richardson, Barbra A.
Husnik, Marla
Brown, Elizabeth R.
Kiweewa, Flavia Matovu
Mayo, Ashley J.
Baeten, Jared M.
Palanee-Phillips, Thesla
van der Straten, Ariane
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE
https://doi.org/10.1007/s10461-018-2261-8
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
https://doi.org/10.1007/s10461-021-03205-z
Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa
https://doi.org/10.1186/s12905-021-01321-5
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Article History
First Online: 14 September 2018
Compliance with Ethical Standards
:
: The authors have no conflicts of interest to declare.
: The ASPIRE trial protocol was approved by the ethics review committee at each site.
: All participants provided written informed consent.